The initial public offering on Aim will provide an exit to shareholders including Novartis, which gave Mereo access to three of its clinical stage therapies last year.

Alex McCracken, managing director who had covered VC relations, has stepped up at SVB to help the bank lend about $100m from its new Ireland office, as well as building its startup banking services in Europe more broadly.

Julia Rebholz has joined Corporate Impact-X (CIX), which published a report at the Global Corporate Venturing Symposium last month on practical ways for corporations to follow the Ignite fund set up by UK-based energy utility Centrica.

Following the opening of the UK's first proton beam treatment centre in 2018 or 2019, Imperial College London and the centre will commence a $17m research partnership.

New investor Greatbatch has led the round with a $5m commitment, with the remaining cash coming from existing stakeholders.

E.ON and other existing backers have returned to provide fresh funding to the heating installation service.

Stem cell company Definigen, a Cambridge spinout, raises $2.3m to launch new pancreatic and lung stem cell products to support predictions of drug candidates before clinical trials.